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oyamoya disease is an idiopathic progressive steno-occlusive disorder of the intracranial
rteries located at the base of the brain. It is associated with the development of compen-
satory extensive network of ﬁne collaterals. Moyamoya disease is considered syndromic
when certain genetic or acquired disorders such as polycystic kidney disease, neuroﬁbro-
matosis, or meningitis are also present. Although the genetic contribution in moyamoya is
indisputable, its cause and pathogenesis remain under discussion. Herein, we report a rare
occurrence of moyamoya syndrome in two European Caucasian siblings in association with
unusual multisystemic malformations (polycystic kidney disease in one, and intestinal
duplication cyst in the other). The karyotype was normal. No mutation in the RFN213 gene
was found, and none of the HLA types linked to moyamoya disease or described in similar
familial cases were identiﬁed. By describing these multisystemic associations, polycystic
kidney disease for the second time, and intestinal malformation for the ﬁrst time in the
literature, our report expands the phenotypic variability of moyamoya syndrome. The
coexistence of disparate malformations among close relatives suggests an underlying
common genetic background predisposing to structural or physiological abnormalities in
different tissues and organs.
 2013 Elsevier Inc. All rights reserved.Introduction
Moyamoya disease is an idiopathic progressive steno-
occlusive disorder of the intracranial arteries located at
the base of the brain. It is associated with the development
of a compensatory extensive network of ﬁne collateral
vessels, the “moyamoya” vessels [1]. The list of genetic or
acquired conditions associated with moyamoya is in
continuous expansion. It includes disorders such as Down
syndrome, polycystic kidney disease, neuroﬁbromatosis,
ﬁbromuscular dysplasia, and meningitis among others.
When these conditions are present, moyamoya is thenDr. Nzwalo; Hospital de
rtugal.
ll rights reserved.named moyamoya syndrome or “quasi-moyamoya” [1-3].
Most affected patients present with ischemic symptoms.
However, in a variable proportion of cases, more often in
adults, cerebral hemorrhage can occur [1-4]. Headache,
epilepsy, dyskinesia, and cognitive disturbances are other
manifestations of moyamoya [1-3]. The familial incidence of
affected ﬁrst-degree relatives is approximately 10% to 12%
in Japan and 2% to 6% in the United States [4]. Very few cases
of familial moyamoya disease have been reported in Europe.
We herein report a rare case of moyamoya syndrome in two
European Caucasian siblings coexisting with polycystic
kidney disease and intestinal duplication cyst.
Case Report
Two previously healthy European Caucasian sisters, without family
history of consanguinity, cerebrovascular disease, malformations, or
H. Nzwalo et al. / Pediatric Neurology 48 (2013) 240e243 241genetic disorders were diagnosed at our institution as having moyamoya
syndrome. Therewas no history of neonatal events, meningitis, or cranial
radiation.
The younger sister was the ﬁrst to be diagnosed. She was admitted at
the age of 11 years after acute onset of involuntary movements in the
right limbs. Six months before admission she started having frequent
falls and difﬁculty in executing ﬁne motor activities with the right hand.
The neurologic examination showed continuous choreoathetosis in the
right hemibody. The remaining general and neurologic examination
results were normal. The brain computed tomography (CT) result was
normal. Magnetic resonance (MR) angiography and digital subtraction
angiography disclosed the presence of asymmetric moyamoya with
marked occlusion of the left anterior and middle cerebral arteries and
a cloudlike ﬂow in the territory of the middle cerebral artery (Fig 1).
Renal ultrasonography showed the presence of bilateral multiple renal
cysts (Fig 2). The patient underwent successful encepha-duro-arterio-
synangiosis with symptomatic remission. The postoperative course
was uneventful. She remains symptom free with normal cognitive and
academic performance after 8 years.
The older sister was diagnosed 4 years later, at age 27, after the
incidental ﬁnding of a chronic parieto-occipital ischemic lesion on
a brain CT scan, obtained because of worsening of chronic tension
headache after a minor head trauma. The general and neurologic
examination results were normal. MR angiography and digital subtrac-
tion angiography disclosed the typical bilateral ﬁndings of moyamoya
with extensive cortical brain collateralization (Fig 1). The abdominal CT
scan showed an intestinal duplication cyst (Fig 2). The patient was
referred for neurosurgical evaluation on two occasions and was not
considered a candidate for revascularization because of the presence of
spontaneous collateralization and atresic superﬁcial temporal artery
limiting direct bypass. She is under treatment with aspirin and remains
without neurologic deterioration.
Both siblings were extensively tested to exclude other causes of
secondary moyamoya including hematologic proﬁle, coagulation
screening, thrombophilias, and autoimmune serologic markers. The HLA
ﬁndings are described in Table 1. The karyotype was normal, and no
mutation in the RFN213 gene was found.Figure 1. MR angiogram shows bilateral but asymmetric features of moyamoya
sibling revealing moyamoya features with extensive collateralization (star). Class
arteries are evident (dashed arrows), and constriction of the arteries at the basDiscussion
The diagnosis of moyamoya is based on the demonstra-
tion of typical angiographic features. Cerebral angiography
is the preferredmethod of diagnosis [1], but high-resolution
MR angiography can sufﬁce [2,3]. Both patients fulﬁlled the
criteria for moyamoya attested by the presence of bilateral
steno-occlusive changes in the terminal portion of the
internal carotid artery, in the proximal portions of the
anterior and middle cerebral arteries, and by the presence
of abnormal vascular networks in the vicinity of the steno-
occlusive vessels [1-3]. The disease has had a benign
evolution in both patients, after neurosurgical intervention
in the younger sister and after conservative treatment in the
older. The incidental ﬁnding of a silent stroke in the older
sister raises the question of screening in close relatives,
which is practically nonexistent in Europe but is increasing
in Japan [4].
There is no evidence to support screening formoyamoya;
however, the dissemination of MR angiography led to early
diagnosis and intervention in countries with relative high
prevalence [4]. Table 1 resumes the clinical and HLA char-
acterization of the previously reported cases of Caucasian
familial moyamoya [5-10]. Screening was only carried out in
one of these reported cases [6]. With increasing evidence of
the advantages of early neurosurgical intervention in
moyamoya, screening of the closest relatives with a nonin-
vasive invasive method such as MR angiography could
reduce the risk of permanent disability from stroke in
symptom-free patients. Most cases of familial moyamoya in
Caucasians are diagnosed in childhood, but the interval is
wide (1-52 years), suggesting that any screening strategydisease in the younger sibling (circle) and cerebral angiography of the older
ic moyamoya “puff of smoke” collateral vessels originating from perforating
e of the brain (arrows) is seen. Abbreviation: MR ¼ Magnetic resonance.
Figure 2. Renal ultrasonoound scan of the younger sibling shows multiple renal cysts (black arrows for the small cysts and white arrow for the biggest cyst),
and abdominal CT scan of the older sibling revealing intestinal duplication cyst (star). Abbreviation: CT ¼ Computed tomography.
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itors. The ideal timing for screening is yet to be determined.
The youngest diagnosed patient was 2 months old, leading
the authors to consider that the disease could have started
in uterus [11].Table 1. Clinical and HLA characterization of the previously reported cases of Caucas
Cases Age and Sex Presentation
Siblings 11 y/F Hemidistony
27 y/F Headache
Father-to-child 46 y/M Ischemic Stroke
23 y/M Ischemic Stroke
24 y/F Ischemic Stroke
Mother-to-child 23 y/F Ischemic Stroke
11 months/F Epilepsy/Ischemic Stroke
Mother-to-child
(Three generations)
52 y/F (Grandmother) Hemorrhagic stroke
23 y/F (Mother) Asymptomatic
19 y/F (Aunt) Ischemic Stroke
6 y/F (Sister) Epilepsy
5 y/M Epilepsy/Ischemic Stroke
Siblings 7 y/M Epilepsy/TIA/Headache
4.5 y/M Epilepsy
Siblings 7 y/M Epilepsy/Ischemic Stroke
5 y/M Epilepsy/TIA
Siblings (twins) 31 y/F Ischemic Stroke
31 y/F Asymptomatic
Father-to-child 1.5 y/M Epilepsy/Stroke
28 y/M TIA
Abbreviations:
F ¼ Female
M ¼ Male
TIA ¼ Transient ischemic attack
y ¼ YearsThis is the second report of polycystic kidney disease
occurring in association with moyamoya [12], and the ﬁrst
to document intestinal malformation in a patient with
moyamoya. The co-occurrence of these disparate malfor-
mations within a family could be a consequence of anian familial moyamoya
HLA Typing Author (Year)
A*02:01, 03:01; B*13:02, 44:02;
DRB1*07:01, *13:01;DQA1*01:03,
*02:01; DQB1*02:03, * 06:03
Current report
A*03:01, 23:01; B*44:02, 44:03;
DRB1*13:01, *13:01;DQA1*01:03,
*01:03; DQB1*06:03, * 06:03
A*02, *24; B*18, * 58; DRB1*03;
DQB1*02, *03
Kraemer et al., 2012 [10]
A*02, *24; B* *35, *58; DRB1*03;
DQB1 *11, *03
Unavailable
Unavailable Papavasiliou et al., 2007 [9]
Unavailable Papavasiliou et al., 2007 [9]
Zafeiriou et al., 2003 [8]
Unavailable Shetty-Alva and Alva 2000[7]
A* *01; B* *35, *57; DRB1 *11:04,
*11:07; DQB1 *03:01, *03:03
Andreone et al., 1999 [6]
Unavailable Setzen et al., 1999 [5]
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causing structural or physiological abnormalities. There is
little knowledge of how genes contribute to moyamoya
syndrome, probably because of its multifactorial nature and
also because of the heterogeneity of the associated genetic
disorders. Mutations in the RNF213 gene, which are now
recognized as a risk factor and that are associated with
aggressive moyamoya, were not found [13,14]. This is in
agreement with the relatively late and benign disease
shown here. None of the HLA types linked to moyamoya or
described in other Caucasian familial cases were identiﬁed.
Furthermore, the HLA alleles found in both siblings are
common in our country, Portugal, which precludes
conclusions on the basis of the HLA type. Our case reinforces
the occurrence of familial moyamoya in Caucasians and
describes a unique combination of multisystemic malfor-
mations that contribute to expansion of the phenotypic
variability of moyamoya syndrome.
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